The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Hemostasis Products Market Research Report 2025

Global Hemostasis Products Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1794936

No of Pages : 106

Ask Your Query

Synopsis

Hemostasis or haemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing. 

The global Hemostasis Products market was valued at US$ 3303.8 million in 2023 and is anticipated to reach US$ 4856.2 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.

The Hemostasis Products market is experiencing steady growth due to the rising incidence of surgical procedures and bleeding disorders. Hemostasis products are crucial in controlling bleeding and promoting clotting during surgeries and in patients with coagulation disorders. The market is driven by advancements in hemostatic technologies, such as topical hemostats, sealants, and adhesives, which offer improved efficacy and ease of use. Additionally, an aging population, increased prevalence of chronic diseases, and a growing emphasis on minimally invasive surgeries contribute to market expansion. The demand for hemostasis products in emergency care and trauma cases is also rising. However, stringent regulatory requirements and the presence of alternative hemostatic techniques may pose challenges to market players.

This report aims to provide a comprehensive presentation of the global market for Hemostasis Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostasis Products.

Report Scope

The Hemostasis Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostasis Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hemostasis Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List)

  • Johnson & Johnson
  • Baxter
  • BD
  • B Braun
  • Gelita
  • Integra Life Sciences
  • Advance Medical Solution
  • Pfizer
  • CSL Behring
  • CryoLife
  • Zimmer Biomet
  • Ferrosan Medical Devices
  • Medtronic
  • Smith & Nephew
  • Z-Medica
  • Cohera Medical
  • Marine Polymer

Segment by Type

  • Absorbable Hemostatic Products
  • Non-absorbable Hemostatic Products

Segment by Application

  • Hospitals
  • Clinics

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostasis Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostasis Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Hemostasis Products Market Overview
1.1 Product Overview and Scope of Hemostasis Products
1.2 Hemostasis Products Segment by Type
1.2.1 Global Hemostasis Products Market Value Comparison by Type (2024-2030)
1.2.2 Absorbable Hemostatic Products
1.2.3 Non-absorbable Hemostatic Products
1.3 Hemostasis Products Segment by Application
1.3.1 Global Hemostasis Products Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Hemostasis Products Market Size Estimates and Forecasts
1.4.1 Global Hemostasis Products Revenue 2019-2030
1.4.2 Global Hemostasis Products Sales 2019-2030
1.4.3 Global Hemostasis Products Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hemostasis Products Market Competition by Manufacturers
2.1 Global Hemostasis Products Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hemostasis Products Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hemostasis Products Average Price by Manufacturers (2019-2024)
2.4 Global Hemostasis Products Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemostasis Products, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemostasis Products, Product Type & Application
2.7 Hemostasis Products Market Competitive Situation and Trends
2.7.1 Hemostasis Products Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hemostasis Products Players Market Share by Revenue
2.7.3 Global Hemostasis Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hemostasis Products Retrospective Market Scenario by Region
3.1 Global Hemostasis Products Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hemostasis Products Global Hemostasis Products Sales by Region: 2019-2030
3.2.1 Global Hemostasis Products Sales by Region: 2019-2024
3.2.2 Global Hemostasis Products Sales by Region: 2025-2030
3.3 Global Hemostasis Products Global Hemostasis Products Revenue by Region: 2019-2030
3.3.1 Global Hemostasis Products Revenue by Region: 2019-2024
3.3.2 Global Hemostasis Products Revenue by Region: 2025-2030
3.4 North America Hemostasis Products Market Facts & Figures by Country
3.4.1 North America Hemostasis Products Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hemostasis Products Sales by Country (2019-2030)
3.4.3 North America Hemostasis Products Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Hemostasis Products Market Facts & Figures by Country
3.5.1 Europe Hemostasis Products Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hemostasis Products Sales by Country (2019-2030)
3.5.3 Europe Hemostasis Products Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostasis Products Market Facts & Figures by Country
3.6.1 Asia Pacific Hemostasis Products Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hemostasis Products Sales by Country (2019-2030)
3.6.3 Asia Pacific Hemostasis Products Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hemostasis Products Market Facts & Figures by Country
3.7.1 Latin America Hemostasis Products Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hemostasis Products Sales by Country (2019-2030)
3.7.3 Latin America Hemostasis Products Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostasis Products Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostasis Products Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hemostasis Products Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hemostasis Products Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemostasis Products Sales by Type (2019-2030)
4.1.1 Global Hemostasis Products Sales by Type (2019-2024)
4.1.2 Global Hemostasis Products Sales by Type (2025-2030)
4.1.3 Global Hemostasis Products Sales Market Share by Type (2019-2030)
4.2 Global Hemostasis Products Revenue by Type (2019-2030)
4.2.1 Global Hemostasis Products Revenue by Type (2019-2024)
4.2.2 Global Hemostasis Products Revenue by Type (2025-2030)
4.2.3 Global Hemostasis Products Revenue Market Share by Type (2019-2030)
4.3 Global Hemostasis Products Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hemostasis Products Sales by Application (2019-2030)
5.1.1 Global Hemostasis Products Sales by Application (2019-2024)
5.1.2 Global Hemostasis Products Sales by Application (2025-2030)
5.1.3 Global Hemostasis Products Sales Market Share by Application (2019-2030)
5.2 Global Hemostasis Products Revenue by Application (2019-2030)
5.2.1 Global Hemostasis Products Revenue by Application (2019-2024)
5.2.2 Global Hemostasis Products Revenue by Application (2025-2030)
5.2.3 Global Hemostasis Products Revenue Market Share by Application (2019-2030)
5.3 Global Hemostasis Products Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Hemostasis Products Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baxter Hemostasis Products Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 BD
6.3.1 BD Corporation Information
6.3.2 BD Description and Business Overview
6.3.3 BD Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BD Hemostasis Products Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 B Braun
6.4.1 B Braun Corporation Information
6.4.2 B Braun Description and Business Overview
6.4.3 B Braun Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
6.4.4 B Braun Hemostasis Products Product Portfolio
6.4.5 B Braun Recent Developments/Updates
6.5 Gelita
6.5.1 Gelita Corporation Information
6.5.2 Gelita Description and Business Overview
6.5.3 Gelita Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Gelita Hemostasis Products Product Portfolio
6.5.5 Gelita Recent Developments/Updates
6.6 Integra Life Sciences
6.6.1 Integra Life Sciences Corporation Information
6.6.2 Integra Life Sciences Description and Business Overview
6.6.3 Integra Life Sciences Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Integra Life Sciences Hemostasis Products Product Portfolio
6.6.5 Integra Life Sciences Recent Developments/Updates
6.7 Advance Medical Solution
6.6.1 Advance Medical Solution Corporation Information
6.6.2 Advance Medical Solution Description and Business Overview
6.6.3 Advance Medical Solution Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Advance Medical Solution Hemostasis Products Product Portfolio
6.7.5 Advance Medical Solution Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Hemostasis Products Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 CSL Behring
6.9.1 CSL Behring Corporation Information
6.9.2 CSL Behring Description and Business Overview
6.9.3 CSL Behring Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
6.9.4 CSL Behring Hemostasis Products Product Portfolio
6.9.5 CSL Behring Recent Developments/Updates
6.10 CryoLife
6.10.1 CryoLife Corporation Information
6.10.2 CryoLife Description and Business Overview
6.10.3 CryoLife Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CryoLife Hemostasis Products Product Portfolio
6.10.5 CryoLife Recent Developments/Updates
6.11 Zimmer Biomet
6.11.1 Zimmer Biomet Corporation Information
6.11.2 Zimmer Biomet Hemostasis Products Description and Business Overview
6.11.3 Zimmer Biomet Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zimmer Biomet Hemostasis Products Product Portfolio
6.11.5 Zimmer Biomet Recent Developments/Updates
6.12 Ferrosan Medical Devices
6.12.1 Ferrosan Medical Devices Corporation Information
6.12.2 Ferrosan Medical Devices Hemostasis Products Description and Business Overview
6.12.3 Ferrosan Medical Devices Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Ferrosan Medical Devices Hemostasis Products Product Portfolio
6.12.5 Ferrosan Medical Devices Recent Developments/Updates
6.13 Medtronic
6.13.1 Medtronic Corporation Information
6.13.2 Medtronic Hemostasis Products Description and Business Overview
6.13.3 Medtronic Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Medtronic Hemostasis Products Product Portfolio
6.13.5 Medtronic Recent Developments/Updates
6.14 Smith & Nephew
6.14.1 Smith & Nephew Corporation Information
6.14.2 Smith & Nephew Hemostasis Products Description and Business Overview
6.14.3 Smith & Nephew Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Smith & Nephew Hemostasis Products Product Portfolio
6.14.5 Smith & Nephew Recent Developments/Updates
6.15 Z-Medica
6.15.1 Z-Medica Corporation Information
6.15.2 Z-Medica Hemostasis Products Description and Business Overview
6.15.3 Z-Medica Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Z-Medica Hemostasis Products Product Portfolio
6.15.5 Z-Medica Recent Developments/Updates
6.16 Cohera Medical
6.16.1 Cohera Medical Corporation Information
6.16.2 Cohera Medical Hemostasis Products Description and Business Overview
6.16.3 Cohera Medical Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Cohera Medical Hemostasis Products Product Portfolio
6.16.5 Cohera Medical Recent Developments/Updates
6.17 Marine Polymer
6.17.1 Marine Polymer Corporation Information
6.17.2 Marine Polymer Hemostasis Products Description and Business Overview
6.17.3 Marine Polymer Hemostasis Products Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Marine Polymer Hemostasis Products Product Portfolio
6.17.5 Marine Polymer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostasis Products Industry Chain Analysis
7.2 Hemostasis Products Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostasis Products Production Mode & Process
7.4 Hemostasis Products Sales and Marketing
7.4.1 Hemostasis Products Sales Channels
7.4.2 Hemostasis Products Distributors
7.5 Hemostasis Products Customers
8 Hemostasis Products Market Dynamics
8.1 Hemostasis Products Industry Trends
8.2 Hemostasis Products Market Drivers
8.3 Hemostasis Products Market Challenges
8.4 Hemostasis Products Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock